Healthcare -
Biotechnology - NASDAQ - US
$ 11.17
-1.97 %
$ 552 M
Market Cap
-3.04
P/E
KALV - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative KALV - KalVista Pharmaceuticals, Inc.
54.3 M
LAST VALUE
43.26%
2 YEAR CAGR
37.79%
5 YEAR CAGR
44.14%
10 YEAR CAGR